CNS metastasis in ROS1+ NSCLC: An urgent call to action, to understand, and to overcome
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference88 articles.
1. Dentification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007
2. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer;Rikova;Cell,2007
3. Further advances in the management of anaplastic lymphoma kinase-mutated non-small-cell lung cancer;Ou;J. Clin. Oncol.,2017
4. https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm625027.htm (Accessed 17 November 2018).
5. Tyrosine kinase gene rearrangements in epithelial malignancies;Shaw;Nat. Rev. Cancer,2013
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Foritinib, a type II ROS1 inhibitor for NSCLC;The Lancet Respiratory Medicine;2024-09
2. A Review of the Molecular Determinants of Therapeutic Response in Non-Small Cell Lung Cancer Brain Metastases;International Journal of Molecular Sciences;2024-06-26
3. Recent nanotechnological aspects and molecular targeting strategies for lung cancer therapy;Journal of Nanoparticle Research;2024-05
4. Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries;The Lancet Regional Health - Europe;2024-03
5. Clinical outcomes of ROS1-positive non-small cell lung cancer with limited access to ROS1-tyrosine kinase inhibitors (TKIs): experience from an Indian tertiary referral centre;ecancermedicalscience;2024-01-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3